TLR2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation through Decrease in Regulatory T Cells...

Area of Science:

• Immunology
• Dermatology
• Molecular Biology

Background:

• Toll-like receptors (TLRs) are implicated in autoimmune diseases.
• Psoriasis is a chronic inflammatory skin condition with complex immune system involvement.

Purpose of the Study:

• To investigate the specific role of Toll-like receptor 2 (TLR2) in the pathogenesis of psoriasis using an imiquimod-induced mouse model.
• To elucidate the mechanisms by which TLR2 influences immune responses in the context of psoriasiform dermatitis.

Main Methods:

• Utilized imiquimod-induced psoriasis-like dermatitis model in wild-type and TLR2 knockout (TLR2 KO) mice.
• Analyzed messenger RNA (mRNA) levels of Foxp-3 and IL-10 in lesional skin.
• Performed flow cytometry on lymph nodes to assess regulatory T cell (Treg) populations.
• Stimulated immune cells with TLR2/1 and TLR2/6 ligands (Pam3CSK4 and Pam2CSK4).
• Conducted adoptive transfer experiments with Tregs.

Main Results:

• TLR2 deficiency unexpectedly exacerbated psoriasiform skin inflammation.
• Reduced mRNA levels of Foxp-3 and IL-10 were observed in TLR2 KO mice.
• A decreased frequency of Tregs was found in the lymph nodes of TLR2 KO mice.
• TLR2 ligand stimulation enhanced IL-10 production by Tregs and dendritic cells (DCs) and promoted Treg proliferation.
• Adoptive transfer of Tregs ameliorated skin inflammation in TLR2 KO mice.

Conclusions:

• TLR2 signaling plays a crucial suppressive role in imiquimod-induced psoriasis-like inflammation.
• TLR2 directly promotes Treg proliferation and IL-10 production, thereby mitigating skin inflammation.
• Targeting TLR2 signaling represents a potential therapeutic strategy for managing psoriasis.